5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation - an effect sensitive to NMDA receptor antagonism

被引:181
作者
King, MV [1 ]
Sleight, AJ
Woolley, ML
Topham, IA
Marsden, CA
Fone, KCF
机构
[1] Univ Nottingham, Sch Biomed Sci, Queens Med Ctr, Inst Neurosci, Nottingham NG7 2UH, England
[2] Hoffmann La Roche Ag, PRBD N, CH-4070 Basel, Switzerland
关键词
5-HT6; receptor; Ro; 04-6790; SB-271046; cognition; object discrimination; glutamate;
D O I
10.1016/j.neuropharm.2004.03.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
5-HT6 receptors are expressed in brain regions associated with learning and memory, and blockade of their function increases central cholinergic and glutamatergic neurotransmission and enhances cognitive processes. This study examined the effects of acute systemic administration of two selective 5-HT6 receptor antagonists Ro 04-6790 and SB-271046(10 mg kg(-1) i.p.) on acquisition, consolidation, and retrieval in the novel object discrimination (NOD) task, a two-trial test of recognition memory in which rats exposed to two identical objects during a familiarisation trial can discriminate a novel from a familiar object during the subsequent choice trial, following inter-trial delays of up to 3 h. 5-HT6 receptor antagonist administration 20 min prior to or immediately after the familiarisation trial, but not 20 min prior to the choice trial reversed the deficit in object discrimination produced by a 4 h inter-trial interval. The nootropic effects of the 5-HT6 receptor antagonists in this task thus appear to involve enhanced consolidation. Pre-treatment with the non-competitive NMDA receptor antagonist MK-801 (0.05 mg kg(-1) i.p.) prevented the effect of Ro 04-6790 on delay-induced deficits in object discrimination. This suggests that the 5-HT6 receptor antagonist-induced enhancement of consolidation involves increased central glutamatergic neurotransmission. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 64 条
[1]   Extensive cytotoxic lesions involving both the rhinal cortices and area TE impair recognition but spare spatial alternation in the rat [J].
Aggleton, JP ;
Keen, S ;
Warburton, EC ;
Bussey, TJ .
BRAIN RESEARCH BULLETIN, 1997, 43 (03) :279-287
[2]   Effects of stress and hippocampal NMDA receptor antagonism on recognition memory in rats [J].
Baker, KB ;
Kim, JJ .
LEARNING & MEMORY, 2002, 9 (02) :58-65
[3]   THE CHOLINERGIC HYPOTHESIS OF GERIATRIC MEMORY DYSFUNCTION [J].
BARTUS, RT ;
DEAN, RL ;
BEER, B ;
LIPPA, AS .
SCIENCE, 1982, 217 (4558) :408-417
[4]   Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats [J].
Bentley, JC ;
Bourson, A ;
Boess, FG ;
Fone, KCF ;
Marsden, CA ;
Petit, N ;
Sleight, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (07) :1537-1542
[5]  
BENTLEY JC, 1997, J PSYCHOPHARMACOL, V11, pA64
[6]  
BENTLEY JC, 1999, BRIT J PHARM P, V126, P66
[7]   5-HT6 receptor antagonists:: lead optimisation and biological evaluation of N-aryl and N-heteroaryl 4-amino-benzene sulfonamides [J].
Bös, M ;
Sleight, AJ ;
Godel, T ;
Martin, JR ;
Riemer, C ;
Stadler, H .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2001, 36 (02) :165-178
[8]   Involvement of 5-HT6 receptors in nigro-striatal function in rodents [J].
Bourson, A ;
Boess, FG ;
Bös, M ;
Sleight, AJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (07) :1562-1566
[9]  
BOURSON A, 1995, J PHARMACOL EXP THER, V274, P173
[10]   5-chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046):: A potent, selective, and orally bioavailable 5-HT6 receptor antagonist [J].
Bromidge, SM ;
Brown, AM ;
Clarke, SE ;
Dodgson, K ;
Gager, T ;
Grassam, HL ;
Jeffrey, PM ;
Joiner, GF ;
King, FD ;
Middlemiss, DN ;
Moss, SF ;
Newman, H ;
Riley, G ;
Routledge, C ;
Wyman, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) :202-205